Document is current

Any future updates will be listed below

Possible Long-Term Efficacy of Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor, for Slowly Progressive Type 1 Diabetes (SPIDDM) in the Stage of Non-Insulin-Dependency: An Open-Label Randomized Controlled Pilot Trial (SPAN-S)

Crossref DOI link: https://doi.org/10.1007/s13300-017-0299-7

Published Online: 2017-09-19

Published Print: 2017-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark